"Discover how Bruker’s Fourier PAT enables high-fidelity process control and optimization for industrial applications.

From our point of view, Bioxtran is a highly undervalued asset with exceptionally strong clinical trial data that warrants further development. We are very happy to provide the capital needed to ...